StellaCyte Bioscience
Contact us

RESEARCH-USE BIOSIMILAR ANTIBODY

Puxitatug

Antibody-drug conjugate · IgG1

VTCN1IgG1RUO

Puxitatug (INT-016; AZD8205 Antibody) is a monoclonal antibody targeting VTCN1/B7-H4. Puxitatug can be used to synthesize antibody-drug conjugates (ADCs), such as Puxitatug samrotecan (HY-171689), which can be applied to various solid tumors. Puxitatug can also be used for researching adjuvant therapies for gastric cancer.

TARGETVTCN1
YAntibody-drug conjugate
CATALOGSC-BS-250
CATALOG NUMBERSC-BS-250
MOLECULAR WEIGHTApprox. 145 kDa
PRODUCT FORMATAntibody-drug conjugate

PRODUCT OVERVIEW

A research-use configuration for comparative antibody studies

Puxitatug (INT-016; AZD8205 Antibody) is a monoclonal antibody targeting VTCN1/B7-H4. Puxitatug can be used to synthesize antibody-drug conjugates (ADCs), such as Puxitatug samrotecan (HY-171689), which can be applied to various solid tumors. Puxitatug can also be used for researching adjuvant therapies for gastric cancer.

Puxitatug is a recombinant research-use antibody directed against VTCN1.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Puxitatug | StellaCyte